Elevate your research with our premium selection of PCR, molecular, and genetic reagents and consumables Product Highlights: PCR Reagents: Unlock precise DNA amplification with our state-of-the-art PCR reagents. Achieve reliable results for a range of applications. Molecular Tools: Explore a comprehensive toolkit for molecular research â?? from DNA and RNA extraction to purification and analysis. Genetic Reagents: Drive your genetic studies forward with high-quality reagents designed for accuracy and reproducibility. Consumables: Discover a wide array of consumables, including tubes, plates, and pipette tips, crafted to meet the demands of your laboratory work. Array Platforms: Embrace versatility with microarray platforms that cater to various applications, from gene expression profiling to genomic variation analysis. Abbott - Biorad - Illumina - Roche - Thermo - BGISeq 500 - Takarabio - sophiagenetics - seracare - paragongenomics - HANDLE HRR NGS Panel - ptglab
Roche is a pharmaceutical and diagnostics company that produces a wide range of products, including reagents for laboratory use. Reagents are substances or compounds used in chemical analysis or other laboratory procedures to detect, produce, or measure other substances. Roche Diagnostics, a division of Roche, is known for manufacturing diagnostic solutions, including a variety of reagents for clinical chemistry, immunoassays, molecular diagnostics, and more. The specific reagents produced by Roche can vary widely depending on the application and the diagnostic platform.
Supplier: RT-PCR test kit, BLUE MASK for killing COVID-19 by copper ion, PP film for sterilizing COVID-19 by Cu-ion: application for elevetor, automatic vending machine, table and desk in office, resutaurant, school etc. where many people contact. Sterilizing efect is valid for many years. Consuming products in hospital and medical facilities like swab, gauze, bandage and many diagnostic test kits
Vannin Healthcare offers several effective COVID-19 tests: SGTi-flex COVID-19 IgM/IgG (25 tests per kit) STANDARD Q COVID-19 IgM/IgG Duo Test (40 tests per kit) Anti-SARS-CoV-2 Rapid Test (50 tests per kit) General Features Can detect and differentiate between IgM and IgG antibodies Convenient: no additional equipment necessary Extremely fast: results in 10-15 minutes Point-of-care testing Allow rapid decision-making in high-stakes situations Why our tests Certified: CE-IVD marked, FDA-cleared, ISO 13485, Korea GMP-certified Reliable: high clinical specificity and selectivity Easy to interpret Can detect antibodies even in asymptomatic patients Vannin Healthcare Global offers various diagnostic and serology tests for identifying the presence of Severe Acute Respiratory Syndrome Coronavirus2 (SARS-CoV-2). SARS-CoV-2 is the virus that causes COVID-19 which means that its presence could indicate that a person has been infected. There are two types of tests currently used to determine the presence of the virus: Molecular diagnostic tests or viral tests (Swab tests) Antibody serology tests (Blood tests) Vannin Healthcare Globalâ??s Serology Tests To find out whether antibodies are present in an obtained sample (whole blood, plasma, or serum), serology tests are used. The presence of antibodies could indicate a past infection. And depending on the type of the immunoglobulins present, it could also determine the approximate time when the infection occurred. After fighting a coronavirus, our bodies are likely to produce two classes of antibodies: IgM and IgG. In the case of SARS-CoV-2, both IgM and IgG are most likely to occur simultaneously within two to three weeks after a personâ??s been infected. For a firmer diagnosis, Vannin Healthcare Global offers serology tests that check for both IgM and IgG antibodies. Can detect and differentiate between IgM and IgG antibodies Differentiating between the antibodies is crucial when it comes to providing proper medical advice to your patients. The appearance of IgM antibodies is the initial response of the organism fighting to suppress the virus. These antibodies could indicate that the patient is still infectious, and advising patients to self-isolate is the appropriate course of action. IgG antibodies can be detected in the blood sample usually within7-10 days after the onset of infection. If a patient has IgG antibodies, and no IgM antibodies, they have developed a temporary immunity to COVID-19. No additional equipment necessary The test design makes it a perfect choice for remote areas without access to fully-equipped laboratories. Simply obtain a blood sample from a patient, and add 10�µl into the appropriate place on the testing cassette along with three drops (90�µl) of the buffer. The results will appear in 10-15 minutes. Point-of-care testing Being easy-to-interpret and fast, it is ideal for rapid decision-making in the ICU or during a consultation with a patient. In medical disaste
Introduction: 4-hydroxyethyl piperazine ethosulfonic acid (HEPES) is an important hydrogen ion buffer, which has a good buffer ability in the pH range of 6.8 to 8.2, and can control a constant pH for a long time. Using a concentration of 10 ~ 50mmol/L, the general culture medium containing 20mmol/L 4-hydroxyethyl piperazine taurine can have a good buffer capacity, and has no toxic effect on cells. Application: HEPES (4-hydroxyethyl piperazinethesulfonic acid) is a non-ionic amphoteric buffer with high polarity, and is inert to a variety of chemical reagents and enzymes. It does not participate in and interfere with the process of biochemical reactions, and has no inhibitory effect on enzyme chemical reactions. Therefore, it can be used specifically for the research of proteins and enzymes that are highly volatile and ph-sensitive to organelles and very volatile. Buffer solution preparation: (1)hepes buffer can be directly added to the prepared culture medium according to the desired concentration, and then filtered to remove bacteria. 2.38 g HEPES was added to each 1000ml of culture medium, the pH was adjusted to 7.2 with lNNaOH after dissolution, and the bacteria were removed by filtration before use. At this time, the concentration of HEPES was 10mmol/L. (2) 100x storage solution (lmol/L) could also be prepared. Before use, 99ml culture solution was added to lml storage solution, and the final concentration was 10mmol/L. lmol/L (100x) hepes buffer was prepared as follows: 23.8gHEPES was dissolved in 90ml double distilled water, the pH was adjusted to 7.5-8.0 with lNNaOH, and then the water was fixed to 100ml, filtered to remove bacteria, divided into vials (2ml/ bottle), and stored at 4�ºC or -20�ºC. Purpose: 1.Biological buffer; Reaction buffer, prehybridization buffer and hybridization buffer for isolation and analysis of RNA nuclear fraction; For RNA with T4RNA 2.Molecular biology grade is used for RNA3' -end labeling with T4 RNA ligase 3.Cell-cell adhesion, short-term cell aggregation culture, cleaning of tissue and cell buffer
Supplier: Disposable syringes and needles (korea, lds), nitrile examination gloves (oem allocation holder), cardinal revosoft, cardinal flexal, covid test kit (pcr, antigen, antibody) fda eua, face masks (3ply, kn95, n95, ffp2 niosh), gowns, ppe
Services: Sea and air freight, trade
Buyer: Nitrile gloves (hartalega, kimberly clark, halyard)
Supplier: Covid RT PCR test kit, 3 ply surgical mask, 3 ply medical mask, kn95, n95, reusable mask, alcohol disinfectant wipes, hand sanitizers, nitrile gloves latex gloves, luer slip syringes, medical gowns PPE supplies and etc
DiaPlexQ Novel Coronavirus (2019-nCoV) Detection Kit Real-Time OneStep RT-PCR based assay system for detection of SARS-CoV-2 [Product Approval] U.S FDA EUA, Health Canada IO, CE-IVD marked The DiaPlexQ Novel Coronavirus (2019-nCoV) Detection Kit is a real-time reverse transcriptase (RT)-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasal aspirates, nasal washes, bronchoalveolar lavage (BAL) fluid and sputum from individuals suspected of COVID-19 by their healthcare provider. Results are for the identification of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. The agent detected may not be the definite cause of disease. Positive results do not rule out bacterial infection or co-infection with other viruses. Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information. The DiaPlexQ Novel Coronavirus (2019-nCoV) Detection Kit is intended for use by qualified clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR and in vitro diagnostic procedures.
Supplier: Surgical masks, nitrile gloves, latex gloves, vg70 respirator, medical gowns, protective goggles, n95 masks, ffp2 masks, ffp3 masks, antigen tests, serological tests, and any medical equipment required by the client.
Services: Import, export, distribution, and sale